The Advanced Medical Technology Association and other trade groups have called on the FDA to extend from one year to two years the period for complying with a proposed rule that would require device firms to electronically file adverse event reports with the agency. AdvaMed said the extension will allow the companies to better manage their design and budget plans "as well as the financial cycles required to secure funding for an electronic solution of this magnitude."

Related Summaries